The NIDDK Disorders of Gastrointestinal Interoception Consortium (DGIC) - Clinical Research Centers (U01 Clinical Trial Not Allowed)

<p>This Notice of Funding Opportunity (NOFO) invites new applications to participate in the Diseases of Gastrointestinal Interoception Consortium (DGIC). &nbsp;The overall objectives of this consortium are to: 1) identify the underlying mechanisms that link altered GI interception more directly to GI dysmotility and symptoms; 2) identify disease or response biomarkers that better assess pathophysiology or treatment efficacy; and 3) leverage state-of-the-art technologies to identify novel therapeutic targets that could be assessed in future clinical trials.&nbsp;</p><p>This NOFO uses a cooperative agreement mechanism (U01) and runs in parallel with a companion NOFO (<a href="https://www.grants.gov/search-results-detail/360623">RFA-DK-28-214)</a>.&nbsp;</p>